Fresenius Medical Care AG (FMS) Raw Materials (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Raw Materials for 17 consecutive years, with $383.3 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Raw Materials rose 4.18% year-over-year to $383.3 million; the TTM figure through Dec 2025 stood at $383.3 million (up 4.18% YoY), while the FY2025 annual figure was $383.3 million, up 4.18% from the prior year.
• Raw Materials came in at $383.3 million for Q4 2025 at Fresenius Medical Care AG, up from $367.9 million in the prior quarter.
• The five-year high for Raw Materials was $517.2 million in Q4 2021, with the low at $313.2 million in Q4 2022.
• Average Raw Materials over 5 years is $394.2 million, with a median of $383.3 million recorded in 2025.
• Across the five-year window, Raw Materials surged 86.62% in 2021 and tumbled 39.44% in 2022, its largest moves.
• Year by year, Raw Materials stood at $517.2 million in 2021, then sank by 39.44% to $313.2 million in 2022, then advanced by 24.29% to $389.3 million in 2023, then fell by 5.48% to $367.9 million in 2024, then gained by 4.18% to $383.3 million in 2025.
• According to Business Quant data, Raw Materials over the past three periods registered $383.3 million, $367.9 million, and $389.3 million for Q4 2025, Q4 2024, and Q4 2023 respectively.